Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03524183 · ClinicalTrials.gov registry record · Phase 2
Virtual Fitness Buddy Ecosystem
A Phase 2 study, sponsored by University of Georgia.
- Completed
- Registry status
- Phase 2
- Development phase
- 964
- Enrollment target
NCT03524183: Completed Phase 2 study, sponsored by University of Georgia.
NCT03524183 is a Phase 2 study that has completed, run by University of Georgia. The registered enrollment target is 964 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (625% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03524183, a Phase 2 study, has completed, sponsored by University of Georgia.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 964 participants
- Enrollment target
Study Summary
The VFB Ecosystem capitalizes on digital technologies' ability to connect parents and children, allowing parents to actively support their child's physical activity, even when parents cannot be present. The VFB is a kiosk-based system that houses a virtual dog programmed to allow children to set self-determined physical activity goals. The children wear Fitbits while performing physical activity. Using the unique data embedded in the Fitbit, the kiosk is able to detect each individual child and automatically connect him or her to a unique, personalized virtual dog. Physical activity data is transmitted automatically from the Fitbit to the kiosk when the child approaches, and the virtual dog provides accurate evaluations of whether the child met the self-determined physical activity goal, offering words of encouragement and physical activity support. The virtual pet functions as a personalized fitness buddy to encourage children to set and meet physical activity goals, promote physical activity self-efficacy, and foster mutually supportive relationships among children, parents, and the virtual pet. This will be particularly helpful for children who receive insufficient amounts of social support in their current environment. Concurrently, the kiosk sends a text message to parents on the child's physical activity progress. Parents are then able to send words of encouragement and communicate with their children via the kiosk, using the text messaging feature of their mobile phones. Thus, even when the parent is not with the child, the virtual pet is designed to serve as a coordinating focus for facilitating parent-child communication. Parents will also receive text messages from the kiosk with a security code to access a website that provides detailed records of the child's physical activity over time.
Primary Outcome
Physical activity of participating children will be assessed with Fitbits and validated with Actigraphs.
Interventions
- BEHAVIORAL Virtual Fitness Buddy Ecosystem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 964 participants |
| Start Date | 2018-08-27 |
| Est. Completion | 2024-06-30 |
| Phase | Phase 2 |
What the finished NCT03524183 record still lists
NCT03524183 is an interventional study that assigns participants to a tested intervention. The registered 964 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (625% higher).
The record links to 0 conditions, and to 1 intervention - of which Virtual Fitness Buddy Ecosystem is the first listed.
NCT03524183 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03524183 about?
NCT03524183 is a clinical study titled "Virtual Fitness Buddy Ecosystem". The VFB Ecosystem capitalizes on digital technologies' ability to connect parents and children, allowing parents to actively support their child's physical activity, even when parents cannot be present. The VFB is a kiosk-based system that houses a virtual dog programmed to allow children to set sel...
What is the current status of trial NCT03524183?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 964 participants. The study started on 2018-08-27. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT03524183?
The interventions under investigation include: Virtual Fitness Buddy Ecosystem (BEHAVIORAL).
Who is sponsoring clinical trial NCT03524183?
This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03524183's enrollment target sits among peer trials
964 28th of 2000 higher than 1,973 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04726241 · 960 participants · Phase 1
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- NCT05142384 · 960 participants · NA
ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start
- NCT05178498 · 960 participants
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
- NCT05946629 · 960 participants · NA
SELUTION 4 De Novo Small Vessel IDE Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI